공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

PCTA 벌룬 카테터 : 의료기기 파이프라인 평가

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Balloons Catheters - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 12월 상품 코드 920868
페이지 정보 영문 195 Pages
가격
US $ 4,000 ₩ 4,442,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 8,884,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 13,327,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


PCTA 벌룬 카테터 : 의료기기 파이프라인 평가 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Balloons Catheters - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 12월 페이지 정보 : 영문 195 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

PCTA 벌룬 카테터(PCTA Balloon Catheters)에 대해 종합적으로 조사하고, 개발 단계별 동향, 제품 주요 개발업체, 현재 진행중인 임상시험, 업계의 최근 개발 동향 등의 정보를 제공합니다.

제1장 목차

제2장 서론

  • PCTA 벌룬 카테터 개요

제3장 개발중인 제품

  • 파이프라인 제품 : 개발 단계별
  • 파이프라인 제품 : 부문별
  • 파이프라인 제품 : 영역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 승인시기별(추정)
  • 진행중인 임상시험

제4장 PCTA 벌룬 카테터 - 개발중인 파이프라인 제품 : 기업별

  • 개발 기업 - 파이프라인 제품 : 개발 단계별
  • 파이프라인 제품 : 개발 단계별

제5장 PCTA 벌룬 카테터 개발 기업 및 제품 개요

  • 3DT Holdings LLC
  • Aachen Resonance GmbH
  • Acrostak(Schweiz) AG
  • AlviMedica Medical Technologies Inc
  • Andramed GmbH
  • Atrium Medical Corp
  • B. Braun Interventional Systems Inc
  • Bolton Medical Inc
  • Boston Scientific Corp
  • BrosMed Medical Co., Ltd
  • Caliber Therapeutics Inc
  • Cardionovum GmbH
  • Concept Medical Inc
  • Cordis Corp
  • CorNova Inc
  • Innovia LLC
  • iVascular SLU
  • Kaneka Corp
  • Lifetech Scientific(Shenzhen) Co Ltd
  • Lithotech Medical Ltd

제6장 PCTA 벌룬 카테터 - 최근 개발 동향

  • Medtronic
  • Neovasc

제7장 부록

LSH 20.01.23

List of Tables

  • Table 1: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
  • Table 2: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment
  • Table 3: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory
  • Table 4: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path
  • Table 5: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date
  • Table 6: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials
  • Table 7: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies - Pipeline Products by Stage of Development
  • Table 8: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
  • Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Conductance Balloon Coronary Post-Dilatation Catheter - Product Status
  • Table 11: Conductance Balloon Coronary Post-Dilatation Catheter - Product Description
  • Table 12: Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: VIAR - Product Status
  • Table 14: VIAR - Product Description
  • Table 15: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: PTCA Balloon - Product Status
  • Table 17: PTCA Balloon - Product Description
  • Table 18: AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Fluydo - Product Status
  • Table 20: Fluydo - Product Description
  • Table 21: Invader CTO - Product Status
  • Table 22: Invader CTO - Product Description
  • Table 23: Invader PTCA Balloon Dilatation Catheter - Product Status
  • Table 24: Invader PTCA Balloon Dilatation Catheter - Product Description
  • Table 25: ProHP - Product Status
  • Table 26: ProHP - Product Description
  • Table 27: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Zero-Profile PTCA Balloon - Product Status
  • Table 29: Zero-Profile PTCA Balloon - Product Description
  • Table 30: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Coronary Stent Balloon Catheter - Product Status
  • Table 32: Coronary Stent Balloon Catheter - Product Description
  • Table 33: B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: SeQuent Please ReX Drug Coated PTCA Balloon Catheter - Product Status
  • Table 35: SeQuent Please ReX Drug Coated PTCA Balloon Catheter - Product Description
  • Table 36: Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Flash PTCA - Product Status
  • Table 38: Flash PTCA - Product Description
  • Table 39: Runner PTCA Balloon Catheter - Product Status
  • Table 40: Runner PTCA Balloon Catheter - Product Description
  • Table 41: Runner Slim PTCA - Product Status
  • Table 42: Runner Slim PTCA - Product Description
  • Table 43: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: 1.2 Zulu PTCA - Product Status
  • Table 45: 1.2 Zulu PTCA - Product Description
  • Table 46: Agent Paclitaxel Coated-PTCA Balloon Catheter - Product Status
  • Table 47: Agent Paclitaxel Coated-PTCA Balloon Catheter - Product Description
  • Table 48: NC Zulu PTCA Post-Dilatation Catheter - Product Status
  • Table 49: NC Zulu PTCA Post-Dilatation Catheter - Product Description
  • Table 50: Next Generation PCB - Product Status
  • Table 51: Next Generation PCB - Product Description
  • Table 52: Zulu PTCA Pre-Dilatation Catheter - Product Status
  • Table 53: Zulu PTCA Pre-Dilatation Catheter - Product Description
  • Table 54: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 55: Agent Paclitaxel Coated-PTCA Balloon Catheter - A 2:1 Randomized Trial Comparing the Agent Paclitaxel-coated PTCA Balloon Catheter Versus SeQuent Please Drug Eluting Balloon Catheter for the Treatment of a Small Vessel De Novo Native Coronary Artery Lesion
  • Table 56: Agent Paclitaxel Coated-PTCA Balloon Catheter - A Prospective Randomized Multicenter Non-inferiority Clinical Study to Determine the Safety and Performance of the Agent Paclitaxel-coated PTCA Balloon Catheter (Hemoteq) Compared to the SeQuent Please Paclitaxel-releasing Coronary Balloon Catheter (B.Braun) for the Treatment of Coronary In-stent Restenosis: AGENT-ISR
  • Table 57: BrosMed Medical Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Product Status
  • Table 59: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Product Description
  • Table 60: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Product Status
  • Table 61: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Product Description
  • Table 62: BrosMed Medical Co., Ltd - Ongoing Clinical Trials Overview
  • Table 63: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Artimes Pro Low Profile 1.00mm and 1.25mm Dilatation Catheters for Pre-dilatation of Stenosis and Occlusion in Patients with Symptomatic Ischemic Heart Disease

List of Figures

  • Figure 1: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
  • Figure 2: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment
  • Figure 3: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory
  • Figure 4: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path
  • Figure 5: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date
  • Figure 6: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019" provides an overview of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Introduction 11

  • 2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Overview 11

3 Products under Development 12

  • 3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development 12
  • 3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment 13
  • 3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory 14
  • 3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path 15
  • 3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date 16
  • 3.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials 17

4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products under Development by Companies 18

  • 4.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies - Pipeline Products by Stage of Development 18
  • 4.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development 20

5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies and Product Overview 22

  • 5.1 3DT Holdings LLC Company Overview 22
    • 5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.2 Aachen Resonance GmbH Company Overview 23
    • 5.2.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.3 Acrostak (Schweiz) AG Company Overview 24
    • 5.3.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.4 AlviMedica Medical Technologies Inc Company Overview 25
    • 5.4.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.5 Andramed GmbH Company Overview 30
    • 5.5.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.6 Atrium Medical Corp Company Overview 31
    • 5.6.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.7 B. Braun Interventional Systems Inc Company Overview 32
    • 5.7.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.8 Bolton Medical Inc Company Overview 33
    • 5.8.1 Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.9 Boston Scientific Corp Company Overview 36
    • 5.9.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.10 BrosMed Medical Co., Ltd Company Overview 42
    • 5.10.1 BrosMed Medical Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.11 Caliber Therapeutics Inc Company Overview 47
    • 5.11.1 Caliber Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.12 Cardionovum GmbH Company Overview 49
    • 5.12.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.13 Concept Medical Inc Company Overview 52
    • 5.13.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.14 Cordis Corp Company Overview 57
    • 5.14.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.15 CorNova Inc Company Overview 58
    • 5.15.1 CorNova Inc Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.16 Innovia LLC Company Overview 61
    • 5.16.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.17 iVascular SLU Company Overview 62
    • 5.17.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.18 Kaneka Corp Company Overview 63
    • 5.18.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.19 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 65
    • 5.19.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.20 Lithotech Medical Ltd Company Overview 66

6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters- Recent Developments 96

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 96
  • 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 98
  • 6.3 Nov 07, 2019: Neovasc appoints cardiovascular industry Veteran Bill Little as Chief Operating Officer 99
  • 6.4 Nov 07, 2019: Neovasc announces third quarter 2019 financial results 100
  • 6.5 Nov 05, 2019: First round of late-breaking clinical trial results announced at VIVA19 103

7 Appendix 192

  • 7.1 Methodology 192
  • 7.2 About GlobalData 195
  • 7.3 Contact Us 195
  • 7.4 Disclaimer 195
Back to Top
전화 문의
F A Q